Exact Mass: 436.3341124
Exact Mass Matches: 436.3341124
Found 318 metabolites which its exact mass value is equals to given mass value 436.3341124,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
27-Deoxy-5b-cyprinol
27-Deoxy-5b-cyprinol is an intermediate in Bile acid synthesis pathway, in a sequence of reactions catalyzed by sterol 27-hydroxylase (CYP27) in the oxidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,27-tetrol into 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid (PMID: 8496170). 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide, a metabolite of 27-Deoxy-5b-cyprinol, is the major bile alcohol component in serum from cerebrotendinous xanthomatosis patients (PMID: 7920441). 27-Deoxy-5b-cyprinol is an intermediate in Bile acid synthesis pathway, in a sequence of reactions catalyzed by sterol 27-hydroxylase (CYP27) in the oxidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,27-tetrol into 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid (PMID: 8496170).
Demethylphylloquinone
Demethylphylloquinone is a form of vitamin K that occurs in nature as part of a series of compounds with a common 2-methyl-1,4 naphthoquinone nucleus and differing isoprenoid side chains at the 3 position. Vitamin K forms comprise a single major plant form, phylloquinone with a phytyl side chain and a family of bacterially synthesized menaquinones (MKs) with multiprenyl side chains. Bacterially produced menaquinones are biologically active forms of vitamin K that are present in high concentrations in the human lower bowel. Both phylloquinone and menaquinones are bioactive in hepatic gamma-carboxylation but long-chain MKs are less well absorbed. Liver stores of vitamin K are relatively small. The hepatic reserves of phylloquinone (approximately 10\\% of the total) are labile and turn over at a faster rate than menaquinones. Vitamin K is recognised as a factor required for normal blood coagulation, and in relation to its role in bone metabolism. Vitamin K is a substrate for a liver microsomal enzyme that catalyzes the conversion of specific glutamyl residues to gamma-carboxyglutamyl residues in a limited number of proteins. These include the vitamin K-dependent clotting factors: prothrombin (factor II), factor VII, factor IX, and factor X. In the absence of vitamin K, nonfunctional clotting factors are synthesized and hemorrhage can result. Vitamin K is a coenzyme for glutamate carboxylase, which mediates the conversion of glutamate to gamma-carboxyglutamate (Gla). There are at least three Gla proteins associated with bone tissue, of which osteocalcin is the most abundant and best known. Trabecular and cortical bone appear to contain substantial concentrations of both phylloquinone and menaquinones. (PMID: 8642453, 8527227, 15018483, 1573141) [HMDB] Demethylphylloquinone is a form of vitamin K that occurs in nature as part of a series of compounds with a common 2-methyl-1,4 naphthoquinone nucleus and differing isoprenoid side chains at the 3 position. Vitamin K forms comprise a single major plant form, phylloquinone with a phytyl side chain and a family of bacterially synthesized menaquinones (MKs) with multiprenyl side chains. Bacterially produced menaquinones are biologically active forms of vitamin K that are present in high concentrations in the human lower bowel. Both phylloquinone and menaquinones are bioactive in hepatic gamma-carboxylation but long-chain MKs are less well absorbed. Liver stores of vitamin K are relatively small. The hepatic reserves of phylloquinone (approximately 10\\% of the total) are labile and turn over at a faster rate than menaquinones. Vitamin K is recognised as a factor required for normal blood coagulation, and in relation to its role in bone metabolism. Vitamin K is a substrate for a liver microsomal enzyme that catalyzes the conversion of specific glutamyl residues to gamma-carboxyglutamyl residues in a limited number of proteins. These include the vitamin K-dependent clotting factors: prothrombin (factor II), factor VII, factor IX, and factor X. In the absence of vitamin K, nonfunctional clotting factors are synthesized and hemorrhage can result. Vitamin K is a coenzyme for glutamate carboxylase, which mediates the conversion of glutamate to gamma-carboxyglutamate (Gla). There are at least three Gla proteins associated with bone tissue, of which osteocalcin is the most abundant and best known. Trabecular and cortical bone appear to contain substantial concentrations of both phylloquinone and menaquinones. (PMID: 8642453, 8527227, 15018483, 1573141).
Ganoderal A
Ganoderal A is found in mushrooms. Ganoderal A is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderal A is found in mushrooms. Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor[1]. Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor[1].
5beta-Cholestane-3alpha,7alpha,24,26-tetrol
5beta-Cholestane-3alpha,7alpha,24,26-tetrol is also known as 5β-cholestan-3α,7α,24,27-tetrol. 5beta-Cholestane-3alpha,7alpha,24,26-tetrol is considered to be practically insoluble (in water) and relatively neutral. 5beta-Cholestane-3alpha,7alpha,24,26-tetrol is a bile acid lipid molecule
5a-Cholestane-3a,7a,12a,25-tetrol
5a-Cholestane-3a,7a,12a,25-tetrol is a bile alcohols which is excreted mainly as glucurono-conjugates in bile and urine, and as unconjugated form in feces of patients with cerebrotendinous xanthomatosis (PMID 3700361).
5beta-Cholestane-3alpha,7alpha,12alpha,25-tetrol
5β-Cholestane-3α,7α,12α,25-tetrol is an intermediate in the bile acid synthetic pathway, and is secreted into the bile and urine following glucuronidation. It does not undergo enterohepatic circulation. In cerebrotendinous xanthomatosis (CTX), a bile acid synthesis disorder caused by sterol 27-hydroxylase (CYP27) deficiency, early intermediates and cholestanol accumulate in a variety of tissues, and glucuronides of 25-hydroxylated bile alcohols are released in bile, blood, and urine (PMID: 11181760). Bile acid synthesis from cholesterol is tightly regulated via a feedback mechanism mediated by the farnesoid X receptor (FXR), a nuclear receptor activated by bile acids. Synthesis via the classic pathway is initiated by a series of cholesterol ring modifications and followed by the side chain cleavage. The enhanced cholesterol 7 alpha-hydroxylase (CYP7A1) expression in CYP27 deficiency may be the result of a decreased flux of bile acids and bile alcohols into the liver, while production of FXR-activating 5β-cholestane-3α,7α,12α,25-tetrol is increased (PMID: 15145977).
5b-Cholestane-3a,7a,12a,23-Tetrol
5b-Cholestane-3a,7a,12a,23-Tetrol is a bile present in the urine samples of patients with cerebrotendinous xanthomatosis (CTX). (PMID 6883710 ).
Varanic acid
Varanic acid is a bile acid that will accumulate in patients with deficiencies in the peroxisomal d-bifunctional protein. The final steps in bile acid biosynthesis take place in peroxisomes and involve oxidative cleavage of the side chain of C27-5beta-cholestanoic acids leading to the formation of the primary bile acids cholic acid and chenodeoxycholic acid. The enoyl-CoA hydratase and beta-hydroxy acyl-CoA dehydrogenase reactions involved in the chain shortening of C27-5beta-cholestanoic acids are catalyzed by peroxisomal d-bifunctional protein. (PMID: 9831634) [HMDB] Varanic acid is a bile acid that will accumulate in patients with deficiencies in the peroxisomal d-bifunctional protein. The final steps in bile acid biosynthesis take place in peroxisomes and involve oxidative cleavage of the side chain of C27-5beta-cholestanoic acids leading to the formation of the primary bile acids cholic acid and chenodeoxycholic acid. The enoyl-CoA hydratase and beta-hydroxy acyl-CoA dehydrogenase reactions involved in the chain shortening of C27-5beta-cholestanoic acids are catalyzed by peroxisomal d-bifunctional protein. (PMID: 9831634).
27-Deoxy-5alpha-cyprinol
27-Deoxy-5alpha-cyprinol is found in fishes. 27-Deoxy-5alpha-cyprinol is isolated from lungfish and car
Manglupenone
Manglupenone is found in fruits. Manglupenone is a constituent of the stem bark of Mangifera indica var. Dusehri Constituent of the stem bark of Mangifera indica variety Dusehri. Manglupenone is found in fruits.
(3beta,5alpha,12beta)-Cholestane-3,7,12,25-tetrol
24,24-Dfhv
C27H42F2O2 (436.31526959999997)
N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide
C28H37FN2O (436.28897639999997)
ganoderal A
Ganoderal A is a triterpenoid. ganoderal A is a natural product found in Ganoderma pfeifferi, Ganoderma, and Ganoderma lucidum with data available. Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor[1]. Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor[1].
(3beta, 5alpha, 6beta)-Cholestane-3, 5, 6, 9-tetrol
(3alpha, 5beta, 7alpha, 12alpha, 23R)-Cholestane-3, 7, 12, 23-tetrol
(20R,24S)-5alpha-cholestane-3beta,6beta,15alpha,24-tetraol
5alpha-Cholestan-3beta,5,6beta,19-tetraol|nephalsterol
5alpha-Cholestan-3beta,5,6beta,7beta-tetrol|5alpha-cholestane-3beta,5,6beta,7beta-tetrol|cholestane-3beta,5alpha,6beta,7beta-tetrol
(3beta,5alpha,6beta,11beta)-cholestane-3,5,6,11-tetrol|cholestane-3beta,5alpha,6beta,11beta-tetrol|menellsteroid A
(3alpha, 5beta, 7alpha)-Cholestane-3, 7, 25, 26-tetrol|(3alpha, 5beta, 7alpha)-Cholestane-3, 7, 26, 27-tetrol
7beta-(1S,5-dimethyl-4-hexenyl)-3aalpha,4,4aalpha,5,6,7,8,8a,9,9aalpha-decahydro-5,8abeta-dimethyl-5-methylenspiro(bicyclo[2.2.2]oct-5-en-2,3(2H)-naphtho[2,3-b]furan)-2-on|7beta-(1S,5-dimethyl-4-hexenyl)-3aalpha,4,4aalpha,5,6,7,8,8a,9,9aalpha-decahydro-5,8abeta-dimethyl-5-methylenspirooct-5-en-2,3(2H)-naphtho<2,3-b>furan>-2-on
19-(p-hydroxyhydrocinnamoyloxy)-ent-kaurenic acid|19--ent-kaurenic acid
9,13-epoxy-3,18;15,16-bis-isopropylidenedioxy-labdane
(22E,24R)-3alpha-ureido-ergosta-4,6,8(14)22-tetraene
(1beta, 3beta, 5alpha, 6beta)-Cholestane-1, 3, 5, 6-tetrol|(1beta,3beta,5alpha,6beta)-cholestane-1,3,5,6-tetraol|1beta,3beta,5alpha,6beta-tetrahydroxycholestane|5alpha-cholestane-1beta,3beta,5,6beta-tetrol|cholestan-1beta,3beta,5alpha,6beta-tetrol|cholestane-1beta,3beta,5alpha,6beta-tetraol|cholestane-1beta,3beta,5alpha,6beta-tetrol
4-hydroxy-2,3-dimethoxy-5-(11-methoxy-3,7,11-trimethyldodeca-2,6-dienyl)-6-methylcyclohex-2-enone
7beta-(1S,5-dimethyl-4-hexenyl)-3aalpha,5,6,7,8,8a,9,9aalpha-octahydro-5,5beta,8abeta-trimethylspiro(bicyclo[2.2.2]oct-5-en-2,3(2H)-naphtho[2,3-b]furan)-2-on|7beta-(1S,5-dimethyl-4-hexenyl)-3aalpha,5,6,7,8,8a,9,9aalpha-octahydro-5,5beta,8abeta-trimethylspirooct-5-en-2,3(2H)-naphtho<2,3-b>furan>-2-on
(3alpha, 5beta, 7alpha, 12alpha, 24S)-Cholestane-3, 7, 12, 24-tetrol
(13Z,15E,17E,22E)-3beta-hydroxymalabarica-13,15,17,22,24-pentaen-12-one
(3R,5S,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-7-hydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5R,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-7-hydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
24,24-difluoro-1α-hydroxyvitamin D3 / 24,24-difluoro-1α-hydroxycholecalciferol
C27H42F2O2 (436.31526959999997)
4,4-difluoro-1α-hydroxyvitamin D3 / 4,4-difluoro-1α-hydroxycholecalciferol
C27H42F2O2 (436.31526959999997)
(5Z,7E)-(1S,3S)-4,4-difluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol
C27H42F2O2 (436.31526959999997)
23,23-difluoro-25-hydroxyvitamin D3 / 23,23-difluoro-25-hydroxycholecalciferol
C27H42F2O2 (436.31526959999997)
24,24-difluoro-25-hydroxyvitamin D3 / 24,24-difluoro-25-hydroxycholecalciferol
C27H42F2O2 (436.31526959999997)
5b-Cholestane-3a,7a,12a,25-tetrol
(25S)-5beta-cholestane-3alpha,7alpha,12alpha,26-tetrol
(25R)-5beta-cholestane-3alpha,7alpha,12alpha,26-tetrol
5beta-Cholestane-3alpha,7alpha,12alpha,26-tetrol
Manglupenone
24,24-difluoro-1alpha-hydroxyvitamin D3
C27H42O2F2 (436.31526959999997)
4,4-difluoro-1alpha-hydroxyvitamin D3
C27H42O2F2 (436.31526959999997)
23,23-difluoro-25-hydroxyvitamin D3
C27H42O2F2 (436.31526959999997)
24,24-difluoro-25-hydroxyvitamin D3
C27H42O2F2 (436.31526959999997)
bialamicol
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Bolmantalate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
2-Dicyclohexylphosphino-2,6-bis(N,N-dimethylamino)biphenyl
C28H41N2P (436.30071960000004)
FGIN-1-27
C28H37FN2O (436.28897639999997)
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
23,23-difluoro-25-hydroxyvitamin D3
C27H42F2O2 (436.31526959999997)
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
(24S)-5beta-cholestane-3alpha,7alpha,12alpha,24-tetrol
5beta-Cholestane-3alpha,7alpha,12alpha,24-tetrol with S-configuration at C-24.
Ergosta-5,7,22,24(28)-tetraen-3beta-yl acetate
A sterol ester that is ergosta-5,7,22,24(28)-tetraen-3beta-ol in which the hydroxyl hydrogen is substituted by an acetyl group.
(1R,3Z)-3-[(2E)-2-[(3aS,7aR)-1-[(2R)-5,5-difluoro-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
C27H42F2O2 (436.31526959999997)
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
5a-Cholestane-3a,7a,12a,25-tetrol
PE(22:1(13Z)/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/22:2(13Z,16Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. 5a-Cholestane-3a,7a,12a,25-tetrol is a bile alcohols which is excreted mainly as glucurono-conjugates in bile and urine, and as unconjugated form in feces of patients with cerebrotendinous xanthomatosis (PMID 3700361).
(3R,5R,7R,8R,9S,10S,12S,13R,14S)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3Z)-3-[(2E)-2-[1-(5,5-difluoro-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
C27H42F2O2 (436.31526959999997)
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
Aculeatol E
An oxaspiro compound that is 1,7-dioxadispiro[5.1.5.2]pentadec-9-en-11-one substituted by hydroxy groups at positions 4 and 13 and a tridecyl group at position 2 (the (2R,4R,6S,8R,13S stereoisomer). It is isolated from the leaves of Amomum aculeatum and exhibits toxicity against some cancer cell lines like human lung carcinoma, hormone-dependent lung carcinoma and human breast carcinoma.
(24S)-5beta-cholestane-3alpha,7alpha,24,26-tetrol
5beta-Cholestane-3alpha,7alpha,24,26-tetrol with S-configuration at C-24.
[3-carboxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropyl]-trimethylazanium
C26H46NO4+ (436.34266560000003)
(22S,24R)-3alpha-ureido-ergosta-4,6,8(14),22-tetraene
A member of the class of ureas that is urea substituted by a (3beta,22E)-ergosta-4,6,8(14),22-tetraen-3-yl group at position 1. Isolated from the fruit bodies of the fungus Chlorophyllum molybdites, it exhibits cytotoxicity against Kato III cells.
[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] hexanoate
[1-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-3-hydroxypropan-2-yl] acetate
[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] butanoate
(1-hydroxy-3-octoxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] octanoate
(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoic acid
Labda-7,14-dien-13(R)-OL-alpha-L-6-deoxyidopyranoside
(1-hydroxy-3-pentanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-hydroxy-3-propanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
(5Z,7E)-(3S)-23,23-difluoro-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol
C27H42F2O2 (436.31526959999997)
(5E,7E)-(1S,3S)-4,4-difluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol
C27H42F2O2 (436.31526959999997)
DG(24:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
L-365260 (hemihydrate)
C24H22N4O2.1/2H2O (436.34132339999996)
L-365260 hemihydrate is an orally active and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 hemihydrate interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors[1][2][3].
4-{11-hydroxy-7,7-dimethoxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl}pentanoic acid
3a,6,6,9b,11a-pentamethyl-1-(6-methylhepta-4,6-dien-2-yl)-1h,2h,3h,3bh,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-4,7-dione
(1r,3as,3br,9as,9bs,11ar)-3a,6,6,9b,11a-pentamethyl-1-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-1h,2h,3h,3bh,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-4,7-dione
3-(6,10-dimethylundeca-3,5,7,9-tetraen-2-ylidene)-7-hydroxy-3a,6,6,9a-tetramethyl-octahydrocyclopenta[a]naphthalen-2-one
methyl 2-{6-methoxy-6-[(14e,16e)-octadeca-14,16-dien-1-yl]-3h-1,2-dioxin-3-yl}acetate
6-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhepta-2,4-dienal
(3s,4e,15z,26e,28s)-triaconta-4,15,26-trien-1,12,29-triyne-3,28-diol
5,8'a-dimethyl-7-(6-methylhept-5-en-2-yl)-5'-methylidene-3'a,4',4'a,6',7',8',9',9'a-octahydrospiro[bicyclo[2.2.2]octane-2,3'-naphtho[2,3-b]fura]-5-en-2'-one
9,11,11-trimethyl-2-methylidene-4-({9,11,11-trimethyl-3-oxotricyclo[4.3.2.0¹,⁵]undecan-2-yl}methyl)tricyclo[4.3.2.0¹,⁵]undecan-3-one
(2r)-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromen-6-yl acetate
(2s,3r,4s,5r,6r)-2-{[(3r)-5-[(1s,4as,8as)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol
(1r,3s,3as,3br,5r,5as,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol
(1r,5r,9s)-5-{[(1r,4e,9s)-11,11-dimethyl-8-methylidenebicyclo[7.2.0]undec-4-en-4-yl]methoxy}-11,11-dimethyl-4,8-dimethylidenebicyclo[7.2.0]undecan-3-one
(3s,4e,15e,18e,28s)-triaconta-4,15,18-trien-1,12,29-triyne-3,28-diol
(1r,3as,3bs,5r,5ar,7s,9ar,9br,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthrene-5,5a,7,9b-tetrol
[(3s,6s)-6-[(2s,5r)-5-[(9z,11z)-hexadeca-9,11-dien-1-yl]oxolan-2-yl]-1,2-dioxan-3-yl]acetic acid
24-methylenecycloartenone
{"Ingredient_id": "HBIN004466","Ingredient_name": "24-methylenecycloartenone","Alias": "NA","Ingredient_formula": "C31H48O","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14349","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
agavegenin d
{"Ingredient_id": "HBIN014845","Ingredient_name": "agavegenin d","Alias": "NA","Ingredient_formula": "C27H48O4","Ingredient_Smile": "CC(CCC(C(C)C1C(CC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C)O)O)CO","Ingredient_weight": "436.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "725","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12095933","DrugBank_id": "NA"}
(1r,3as,5ar,5br,7ar,11ar,11br,13as,13br)-5a,5b,8,8,11a-pentamethyl-9-oxo-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,11bh,12h,13h,13ah,13bh-cyclopenta[a]chrysene-3a-carbaldehyde
(4s,5r,6r)-6-[(12z)-henicos-12-en-1-yl]-4,5,6-trihydroxycyclohex-2-en-1-one
1-(5,6-dimethylhept-3-en-2-yl)-5,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
2-{[5-(2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol
(1r,3r,3as,3br,5s,5as,6r,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-6-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,6,7-tetrol
(2e,4e,6r)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhepta-2,4-dienal
5,5',8'a-trimethyl-7-(6-methylhept-5-en-2-yl)-5',6',7',8',9',9'a-hexahydro-3'ah-spiro[bicyclo[2.2.2]octane-2,3'-naphtho[2,3-b]fura]-5-en-2'-one
(1r,3r,3as,3br,5s,5as,6r,7s,9ar,9bs,11ar)-1-[(2s,3e,5r)-6-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,6,7-tetrol
(6bs,8as,11r,12ar,12bs,14ar)-3-hydroxy-11-(hydroxymethyl)-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,10,12,12a,13,14-octahydropicen-2-one
(2s,3r,4s,5s,6s)-2-{[(3r)-5-[(1s,4as,8as)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol
1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol
1-(6-hydroxy-5-methylhex-3-en-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,6,7-tetrol
6a,6b,11,12,14b-pentamethyl-4-methylidene-8a-(prop-1-en-2-yl)-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-ol
(5z)-5-[(2r)-2-[(1r,3ar,5as,7r,9as,9br,11ar)-7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]propylidene]-4-isopropylpyrrol-2-ol
(4r)-4-[(9as,11s,11ar)-11-hydroxy-7,7-dimethoxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]pentanoic acid
n-[1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]carbamimidic acid
(4s,5r,6r)-6-(henicos-12-en-1-yl)-4,5,6-trihydroxycyclohex-2-en-1-one
11-hydroxy-10-methoxy-2,4a,6a,9,12b,14a-hexamethyl-2,4,5,6,6b,13,14,14b-octahydro-1h-picen-3-one
(3s,4ar,6ar,6bs,8as,11r,12s,12ar,14ar,14br)-6a,6b,11,12,14b-pentamethyl-4-methylidene-8a-(prop-1-en-2-yl)-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-ol
(1s,5r,6s,9s)-9,11,11-trimethyl-2-methylidene-4-{[(1s,5s,6s,9s)-9,11,11-trimethyl-3-oxotricyclo[4.3.2.0¹,⁵]undecan-2-yl]methyl}tricyclo[4.3.2.0¹,⁵]undecan-3-one
2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromen-6-yl acetate
(1r,3as,3bs,5r,5ar,7s,9r,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7,9-tetrol
(1s,4r,5s,6s,9s)-9,11,11-trimethyl-2-methylidene-4-{[(1s,2s,5s,6s,9s)-9,11,11-trimethyl-3-oxotricyclo[4.3.2.0¹,⁵]undecan-2-yl]methyl}tricyclo[4.3.2.0¹,⁵]undecan-3-one
(1r,5r,9s)-5-{[(1r,4z,9s)-11,11-dimethyl-8-methylidenebicyclo[7.2.0]undec-4-en-4-yl]methoxy}-11,11-dimethyl-4,8-dimethylidenebicyclo[7.2.0]undecan-3-one
(2s,3r,4r,5r,6s)-2-{[(3r)-5-[(1s,4as,8as)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol
7-{5-[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpent-2-en-1-yl}-6-amino-9-methylpurin-9-ium
[(1s,4s,5r,9s,10r,13r)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl 3-(4-hydroxyphenyl)propanoate
(1r,3r,3as,3br,5s,5as,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol
(9z,12z)-n-[2-(1h-indol-3-yl)-2-oxoethyl]octadeca-9,12-dienimidic acid
(1r,2s,3as,3br,5as,7s,9as,9bs,11as)-1-[(2s,3s,6s)-3,7-dihydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,7-diol
(4e,15z,26e)-triaconta-4,15,26-trien-1,12,29-triyne-3,28-diol
methyl 2-[(3r,6r)-6-methoxy-6-[(14e,16e)-octadeca-14,16-dien-1-yl]-3h-1,2-dioxin-3-yl]acetate
2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)chromen-6-yl acetate
n-[2-(1h-indol-3-yl)-2-oxoethyl]octadeca-9,12-dienimidic acid
6-amino-7-[(2e)-3,7-dimethyl-9-[(1r,6s)-1,2,6-trimethyl-4-oxocyclohex-2-en-1-yl]nona-2,6-dien-1-yl]-9-methylpurin-9-ium
(1r,2s,3'ar,4r,5's,7s,8'ar,9'ar)-5,5',8'a-trimethyl-7-[(2s)-6-methylhept-5-en-2-yl]-5',6',7',8',9',9'a-hexahydro-3'ah-spiro[bicyclo[2.2.2]octane-2,3'-naphtho[2,3-b]fura]-5-en-2'-one
4,13-dihydroxy-2-tridecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one
ethyl 4-{4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}pentanoate
9a,11a-dimethyl-1-(6-methylheptan-2-yl)-tetradecahydrocyclopenta[a]phenanthrene-4,5,5a,7-tetrol
(1r,2s,9as,11as)-1-[(2s,3r,6s)-3,7-dihydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,7-diol
(3r)-n-{2-[(1e,7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxyhexadecanimidic acid
C24H40N2O5 (436.29370700000004)